← 전체 보충제 목록

카바

Kava (Piper methysticum)

📑 PubMed 19편 🌿 허브

📚 관련 논문 (19편)

1.
Effect of kava (Piper methysticum) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial.
Phytotherapy research : PTR 2023 PMID:37767766

1. Phytother Res. 2023 Dec;37(12):5897-5903. doi: 10.1002/ptr.7999. Epub 2023 Sep 28. Effect of kava (Piper methysticum) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial. Cribb L(1), Sarris J(2)(3), Savage KM

2.
Kava (Piper methysticum) in the United States: the quiet rise of a substance with often subtle effects.
The American journal of drug and alcohol abuse 2023 PMID:36410029

2. Am J Drug Alcohol Abuse. 2023 Jan 2;49(1):85-96. doi: 10.1080/00952990.2022.2140292. Epub 2022 Nov 21. Kava (Piper methysticum) in the United States: the quiet rise of a substance with often subtle effects. Pont-Fernandez S(1), Kheyfets M(1), Rogers JM(1), Smith KE(1), Epstein DH(1). Author

3.
Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.
PloS one 2016 PMID:27332705

3. PLoS One. 2016 Jun 22;11(6):e0157700. doi: 10.1371/journal.pone.0157700. eCollection 2016. Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism. Chua HC(1), Christensen ET(1)(2), Hoestgaard-Jensen K(2), H

4.
Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy.
Current drug metabolism 2015 PMID:26526838

4. Curr Drug Metab. 2015;17(1):52-64. doi: 10.2174/1389200216666151103115053. Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy. Fasinu PS(1), Gurley BJ, Walker LA. Author information: (1)National Center for Natural products Research, School of Pharmacy, Univer

5.
Tradition and toxicity: evidential cultures in the kava safety debate.
Social studies of science 2011 PMID:21879526

5. Soc Stud Sci. 2011 Jun;41(3):361-84. doi: 10.1177/0306312710395341. Tradition and toxicity: evidential cultures in the kava safety debate. Baker JD(1). Author information: (1)Department of Anthropology, University of Hawai'i at Mānoa, Honolulu, HI 96822, USA. bakerjon@hawaii.edu This paper e

6.
Kava (Piper methysticum).
Journal of the Society for Integrative Oncology 2009 PMID:19883532

6. J Soc Integr Oncol. 2009 Fall;7(4):170-2. Kava (Piper methysticum). [No authors listed] PMID: 19883532 [Indexed for MEDLINE]

7.
Interactions between herbal medicines and prescribed drugs: an updated systematic review.
Drugs 2009 PMID:19719333

7. Drugs. 2009;69(13):1777-98. doi: 10.2165/11317010-000000000-00000. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Izzo AA(1), Ernst E. Author information: (1)Department of Experimental Pharmacology, University of Naples Federico II, via D Montesano

8.
Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.
Molecular nutrition & food research 2008 PMID:18214849

8. Mol Nutr Food Res. 2008 Jul;52(7):755-63. doi: 10.1002/mnfr.200600300. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Gurley BJ(1), Swain A, Hubbard MA, Williams DK, Barone

9.
Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.
Clinical pharmacology and therapeutics 2008 PMID:17495878

9. Clin Pharmacol Ther. 2008 Jan;83(1):61-9. doi: 10.1038/sj.clpt.6100222. Epub 2007 May 9. Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. Gurley BJ(1), Swain A, Hubbard MA, Hartsfield F, Thaden J, Williams DK

10.
Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans.
Drug metabolism and disposition: the biological fate of chemicals 2007 PMID:17079360

10. Drug Metab Dispos. 2007 Feb;35(2):240-5. doi: 10.1124/dmd.106.012708. Epub 2006 Nov 1. Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Gurley BJ(1), Swain A, Barone GW, Williams DK, Breen P, Yates CR, Stuart

11.
Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2006 PMID:16428028

11. Phytomedicine. 2006 Feb;13(3):192-5. doi: 10.1016/j.phymed.2004.07.005. Epub 2005 Jun 28. Kavalactones fail to inhibit alcohol dehydrogenase in vitro. Anke J(1), Fu S, Ramzan I. Author information: (1)Faculty of Pharmacy, University of Sydney, NSW, Australia. In recent years, Kava kava (Pip

12.
The protective effects of Kava (Piper Methysticum) constituents in cancers: A systematic review.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2019 PMID:31172600

12. J Oral Pathol Med. 2019 Aug;48(7):510-529. doi: 10.1111/jop.12900. Epub 2019 Jul 8. The protective effects of Kava (Piper Methysticum) constituents in cancers: A systematic review. Celentano A(1), Tran A(1), Testa C(1), Thayanantha K(1), Tan-Orders W(1), Tan S(1), Syamal M(1), McCullough MJ

13.
Kava for Generalized Anxiety Disorder: A Review of Current Evidence.
Journal of alternative and complementary medicine (New York, N.Y.) 2018 PMID:29641222

13. J Altern Complement Med. 2018 Aug;24(8):770-780. doi: 10.1089/acm.2018.0001. Epub 2018 Apr 11. Kava for Generalized Anxiety Disorder: A Review of Current Evidence. Ooi SL(1), Henderson P(2), Pak SC(2). Author information: (1)1 Centre for Complementary and Alternative Medicine , Singapore, Si

14.
Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Advances in therapy 2018 PMID:29508154

14. Adv Ther. 2018 Mar;35(3):261-288. doi: 10.1007/s12325-018-0680-6. Epub 2018 Mar 5. Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials. Barić H(1), Đorđević V(2), Cerovečki I(3), Trkulja V(4).

15.
Neurocognitive effects of kava (Piper methysticum): a systematic review.
Human psychopharmacology 2011 PMID:21437989

15. Hum Psychopharmacol. 2011 Mar;26(2):102-11. doi: 10.1002/hup.1180. Epub 2011 Mar 16. Neurocognitive effects of kava (Piper methysticum): a systematic review. LaPorte E(1), Sarris J, Stough C, Scholey A. Author information: (1)Brain Sciences Institute, University of Technology, Melbourne, Vic

16.
Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
Journal of alternative and complementary medicine (New York, N.Y.) 2009 PMID:19614563

27. J Altern Complement Med. 2009 Aug;15(8):827-36. doi: 10.1089/acm.2009.0066. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders. Sarris J(1), Kavanagh DJ. Author information: (1)School of Medicine, The University of Queensland, Royal Brisbane and Women's Hospita

17.
Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration.
Expert opinion on drug safety 2005 PMID:16011454

44. Expert Opin Drug Saf. 2005 Jul;4(4):779-94. doi: 10.1517/14740338.4.4.779. Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Ulbricht C(1), Basch E, Boon H, Ernst E, Hammerness P, Sollars D, Tsourounis C, Woods J, Bent S. Author information: (1)Natura

18.
A systematic review of the safety of kava extract in the treatment of anxiety.
Drug safety 2002 PMID:11994028

50. Drug Saf. 2002;25(4):251-61. doi: 10.2165/00002018-200225040-00003. A systematic review of the safety of kava extract in the treatment of anxiety. Stevinson C(1), Huntley A, Ernst E. Author information: (1)Department of Complementary Medicine, University of Exeter, Exeter, United Kingdom. T

19.
Interactions between herbal medicines and prescribed drugs: a systematic review.
Drugs 2001 PMID:11772128

49. Drugs. 2001;61(15):2163-75. doi: 10.2165/00003495-200161150-00002. Interactions between herbal medicines and prescribed drugs: a systematic review. Izzo AA(1), Ernst E. Author information: (1)Department of Experimental Pharmacology, University of Naples 'Federico II', Naples, Italy. Despite

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.